GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Vision Biotechnology Co Ltd (ROCO:3218) » Definitions » Financial Strength

Universal Vision Biotechnology Co (ROCO:3218) Financial Strength : 8 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Universal Vision Biotechnology Co Financial Strength?

Universal Vision Biotechnology Co has the Financial Strength Rank of 8. It shows strong financial strength and is unlikely to fall into distressed situations.

Good Sign:

Universal Vision Biotechnology Co Ltd shows strong financial strength.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Universal Vision Biotechnology Co's Interest Coverage for the quarter that ended in Dec. 2023 was 80.85. Universal Vision Biotechnology Co's debt to revenue ratio for the quarter that ended in Dec. 2023 was 0.20. As of today, Universal Vision Biotechnology Co's Altman Z-Score is 9.58.


Competitive Comparison of Universal Vision Biotechnology Co's Financial Strength

For the Medical Devices subindustry, Universal Vision Biotechnology Co's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Vision Biotechnology Co's Financial Strength Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Vision Biotechnology Co's Financial Strength distribution charts can be found below:

* The bar in red indicates where Universal Vision Biotechnology Co's Financial Strength falls into.



Universal Vision Biotechnology Co Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Universal Vision Biotechnology Co's Interest Expense for the months ended in Dec. 2023 was NT$-4 Mil. Its Operating Income for the months ended in Dec. 2023 was NT$318 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$613 Mil.

Universal Vision Biotechnology Co's Interest Coverage for the quarter that ended in Dec. 2023 is

Interest Coverage=-1*Operating Income (Q: Dec. 2023 )/Interest Expense (Q: Dec. 2023 )
=-1*318.475/-3.939
=80.85

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Universal Vision Biotechnology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

2. Debt to revenue ratio. The lower, the better.

Universal Vision Biotechnology Co's Debt to Revenue Ratio for the quarter that ended in Dec. 2023 is

Debt to Revenue Ratio=Total Debt (Q: Dec. 2023 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(165.243 + 613.018) / 3971.504
=0.20

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Universal Vision Biotechnology Co has a Z-score of 9.58, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 9.58 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Vision Biotechnology Co  (ROCO:3218) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Universal Vision Biotechnology Co has the Financial Strength Rank of 8. It shows strong financial strength and is unlikely to fall into distressed situations.


Universal Vision Biotechnology Co Financial Strength Related Terms

Thank you for viewing the detailed overview of Universal Vision Biotechnology Co's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Vision Biotechnology Co (ROCO:3218) Business Description

Traded in Other Exchanges
N/A
Address
No. 3-1, Yuanyuan Street, 4th Floor, Nangang District, Taipei, TWN, 115
Universal Vision Biotechnology Co Ltd provides eye treatment and related medical services in Taiwan. It also provides optical devices, glasses, lens and other vision aid products, optometric services, sales and leasing of medical devices, providing of hospital management and technical consultancy services.

Universal Vision Biotechnology Co (ROCO:3218) Headlines

No Headlines